DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
Agency: Dept. of the Army -- USAMRAA
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.
Distinctive Features:
• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.
• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Additional information
Grantor contact information
Description
eBRAP Help Desk
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526LCRPPCOSA_GG.pdf | FY26 LCRP PCOSA Program Announcement | May 6, 2026 02:44 PM UTC |
Link to additional information
--
Closing: September 2, 2026
Award
$1,950,000
Program Funding
2
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
HT942526LCRPPCOSA
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
2
Posted date:
May 5, 2026
Archive date:
October 2, 2026
